Product Image

Ginkgo Biloba

Mason Natural
4.7
★ ★ ★ ★ ★
(7533 ratings)
Ginkgo
Product Image
Score76
A simple, concentrated ginkgo extract at a plausible amount. The 4:1 ratio is useful context but not a substitute for active-marker data.
How scoring works
Quantity:60 Capsule(s) • (60 servings)
Goals:
Brain Health
Cognitive Support
Productivity Boost

Score 76

A simple, concentrated ginkgo extract at a plausible amount. The 4:1 ratio is useful context but not a substitute for active-marker data.
How scoring works
$5.10($0.08 per serving)
iHerb
$ 5.11
Amazon
$ 5.10
Report prices

Analysis

The capsule supplies 125 mg of a 4:1 ginkgo leaf extract. That ratio indicates concentration, but it does not state flavone-glycoside, terpene-lactone, or ginkgolic-acid specifications.

Ginkgo may support cerebral circulation, memory, and mental clarity in selected users. Benefit for immediate productivity or broad vision support remains uncertain and depends on extract quality.

The focused capsule suits budget-conscious users who want a concentrated ginkgo product. Shoppers who prioritize verified clinical comparability should look for complete marker standardization.

Who is it for
  • Adults seeking a concentrated ginkgo capsule
  • Budget-conscious cognitive-support users
  • People who prefer single-herb formulas
Best for
  • General memory-support routines
  • Cerebral-circulation support
  • Simple daily ginkgo use

Pros

  • Clearly states a concentrated extract ratio
  • Provides a plausible daily amount
  • Focused single-ingredient design

Cons

  • No marker percentages
  • No ginkgolic-acid purity limit
  • Concentration ratio does not establish clinical equivalence

Warnings

  • Ginkgo may increase bleeding risk with anticoagulants or antiplatelet medicines.
  • Headache, dizziness, or digestive upset can occur.
  • Perioperative use should be reviewed with the surgical team.

Nutrient quality

80 High impact

A concentrated extract ratio is stated, but it does not verify active-marker levels or purity. The formula supplies a full target-range extract amount, with no obvious overdosing.

.

Ingredient transparency

78 High impact

The main active amounts are clearly listed, and no proprietary blend hides them. Intake directions, non-active ingredients, and some extract-quality details are absent from the supplied data.

.

Customer satisfaction

70 High impact

The supplied average is strong and the response volume is large. No detailed feedback is provided to assess recurring complaints or fit with the intended purpose.

.

Value for money

72 High impact

The serving cost is appealing, but incomplete extract verification limits confidence in value. A fully standardized extract would provide a more dependable comparison.

.
Report analysis

Goals

Brain Health
Impact
High effect
B+ Goal FitB- Strength of SupportC- CoverageA+ Formula Quality

Ginkgo is directly relevant to cerebral circulation and cognitive performance. The 125 mg amount of a 4:1 extract is plausible, but the absence of flavone-glycoside and terpene-lactone percentages limits comparison with studied extracts.

The single-botanical design is focused and provides useful depth without unrelated nutrients. Ginkgo may increase bleeding risk when combined with anticoagulant or antiplatelet medicines, which is the main product-specific safety concern.

Study evidence
Ginkgo Supportive 90 studies
Cognitive Support
Impact
High effect
B+ Goal FitC Strength of SupportD- CoverageA+ Formula Quality

Ginkgo may support cerebral circulation and memory, particularly in older adults with cognitive decline. Benefits in healthy adults are less consistent and depend on using a properly standardized extract.

The concentrated extract amount is clear, but flavone glycosides, terpene lactones, and ginkgolic-acid limits are not disclosed. The focused capsule avoids padding, although its clinical comparability remains uncertain.

Study evidence
Ginkgo Supportive 87 studies
Productivity Boost
Impact
High effect
C+ Goal FitC- Strength of SupportD CoverageA Formula Quality

Ginkgo may support mental performance through cerebral circulation, but it is not a reliable acute productivity enhancer. Evidence depends heavily on standardized extracts with known marker percentages.

The 125 mg four-to-one extract amount is transparent, yet no flavone glycoside, terpene lactone, or ginkgolic acid limits are supplied. Ginkgo may increase bleeding risk with anticoagulant or antiplatelet medicines.

Study evidence
Ginkgo Supportive 20 studies
Ginkgo Supportive 12 studies
Mental Focus
Impact
Moderate effect
B- Goal FitD+ Strength of SupportD- CoverageB+ Formula Quality

Ginkgo may support mental clarity through cerebral circulation, but evidence for reliable attention gains is mixed. The concentrated extract amount could be useful, yet its clinical comparability is uncertain.

No flavone glycoside, terpene lactone, or ginkgolic-acid specification is given. The single-ingredient design is focused, though it covers only one indirect cognitive pathway.

Study evidence
Ginkgo Supportive 28 studies
Vision Support
Impact
Moderate effect
F Goal FitD+ Strength of SupportF CoverageA- Formula Quality

Ginkgo may support ocular microcirculation in specific situations, but it is not a foundational vision nutrient. Human evidence for broad visual benefits remains limited compared with carotenoids and established antioxidant combinations.

The extract amount is clear, yet a four-to-one ratio does not establish flavone glycoside or terpene lactone delivery. A focused capsule avoids padding but leaves potency and purity uncertain.

Study evidence
Ginkgo Supportive 11 studies

Ingredients

IngredientAmount per serving
Ginkgo Biloba leaves 4:1 extract
125 mg
Gluten Free Adults 18–50
Report overview
Ginkgo · 125 mg OverallScore48
F Active Ingredient Quality & BioavailabilityA+ Dose, Safety & Label TransparencyF Value

The low-cost capsule supplies a clearly stated amount of concentrated ginkgo extract. A ratio alone does not confirm the key flavone glycoside and terpene lactone levels, so clinical comparability remains uncertain. No ginkgolic-acid purity limit or recognized branded extract is disclosed.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.
    Herrschaft H; Nacu A; Likhachev S; Sholomov I; Hoerr R; Schlaefke S · Journal of psychiatric research · 2012
    Randomized trial410 participantsBrain Health forGinkgo
  2. Ginkgo for elderly people with dementia and age-associated memory impairment: a randomized clinical trial.
    van Dongen M; van Rossum E; Kessels A; Sielhorst H; Knipschild P · Journal of clinical epidemiology · 2003
    Randomized trial214 participantsBrain Health forGinkgo
  3. Ginkgo biloba extract EGb 761 in patients with dementia and a history of cerebral infarction-meta-analysis of pooled data from randomised clinical trials.
    Feng JX; Zheng MQ; Tian X; Zimmermann A; Wang AX; Meng X · Frontiers in neurology · 2026
    Meta-analysis488 participants4 studies pooledBrain Health forGinkgo
  4. Ginkgo biloba Extract EGb 761 in the Treatment of Patients with Mild Neurocognitive Impairment: A Systematic Review.
    Hort J; Duning T; Hoerr R · Neuropsychiatric disease and treatment · 2023
    Systematic review946 participants9 studies pooledMental Focus forGinkgo
  5. Is Ginkgo biloba a cognitive enhancer in healthy individuals? A meta-analysis.
    Laws KR; Sweetnam H; Kondel TK · Human psychopharmacology · 2014
    Meta-analysis1,132 participants13 studies pooledMental Focus forGinkgo
  6. Modulation of cognition and mood following administration of single doses of Ginkgo biloba, ginseng, and a ginkgo/ginseng combination to healthy young adults.
    Kennedy DO; Scholey AB; Wesnes KA · Physiology & behavior · 2002
    Randomized trial20 participantsMental Focus forGinkgo
  7. The dose-dependent cognitive effects of acute administration of Ginkgo biloba to healthy young volunteers.
    Kennedy DO; Scholey AB; Wesnes KA · Psychopharmacology · 2001
    Randomized trial20 participantsProductivity Boost forGinkgo
  8. Dietary Flavonoids and Human Cognition: A Meta-Analysis.
    Cheng N; Bell L; Lamport DJ; Williams CM · Molecular nutrition & food research · 2022
    Meta-analysis5,519 participants80 studies pooledProductivity Boost forGinkgo
  9. Effects of Ginkgo biloba on alertness and chemosensory function in healthy adults.
    Mattes RD; Pawlik MK · Human psychopharmacology · 2004
    Randomized trial39 participantsProductivity Boost forGinkgo
  10. [Ginkgo extract in impaired vision--treatment with special extract EGb 761 of impaired vision due to dry senile macular degeneration].
    Fies P; Dienel A · Wiener medizinische Wochenschrift (1946) · 2002
    Randomized trial99 participantsVision Support forGinkgo
  11. Ginkgo biloba extract for age-related macular degeneration.
    Evans JR · The Cochrane database of systematic reviews · 2013
    Systematic review119 participants2 studies pooledVision Support forGinkgo
  12. Electrophysiological analysis of the effects of ginkgo biloba on visual processing in older healthy adults.
    Page JW; Findley J; Crognale MA · The journals of gerontology. Series A, Biological sciences and medical sciences · 2006
    Clinical trialVision Support forGinkgo
  13. Efficacy of Ginkgo biloba extract EGb 761® in dementia with behavioural and psychological symptoms: A systematic review.
    von Gunten A; Schlaefke S; Überla K · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2017
    Meta-analysis1,628 participants4 studies pooledCognitive Support Brain Health forGinkgo
  14. Ginkgo biloba Extract (EGb761), Cholinesterase Inhibitors, and Memantine for the Treatment of Mild-to-Moderate Alzheimer's Disease: A Network Meta-Analysis.
    Thancharoen O; Limwattananon C; Waleekhachonloet O; Rattanachotphanit T; Limwattananon P; Limpawattana P · Drugs & aging · 2019
    Meta-analysisCognitive Support forGinkgo
  15. Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761. Findings from a randomized controlled trial.
    Bachinskaya N; Hoerr R; Ihl R · Neuropsychiatric disease and treatment · 2011
    Randomized trial410 participantsCognitive Support forGinkgo
  16. Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis.
    Tan MS; Yu JT; Tan CC; Wang HF; Meng XF; Wang C; Jiang T; Zhu XC; Tan L · Journal of Alzheimer's disease : JAD · 2015
    Meta-analysis2,561 participants9 studies pooledBrain Health forGinkgo
  17. Ginkgo biloba extract EGb 761 is safe and effective in the treatment of mild dementia - a meta-analysis of patient subgroups in randomised controlled trials.
    Riepe M; Hoerr R; Schlaefke S · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2025
    Meta-analysis782 participants4 studies pooledBrain Health Productivity Boost forGinkgo
  18. Ginkgo biloba extract EGb 761® improves cognition and overall condition after ischemic stroke: Results from a pilot randomized trial.
    Cui M; You T; Zhao Y; Liu R; Guan Y; Liu J; Liu X; Wang X; Dong Q · Frontiers in pharmacology · 2023
    Randomized trial201 participantsBrain Health Productivity Boost forGinkgo
  19. Efficacy of ginkgo diterpene lactone meglumine on cognitive function in patients with acute ischemic stroke: a predefined exploratory analysis of a multicenter, double-blind, randomized controlled trial.
    Tian X; Xu Q; Xia X; Zhang Y; Meng X; Wang A · Journal of neurology · 2024
    Randomized trial3,163 participantsCognitive Support forGinkgo
  20. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.
    Le Bars PL; Katz MM; Berman N; Itil TM; Freedman AM; Schatzberg AF · JAMA · 1997
    Randomized trial309 participantsCognitive Support Productivity Boost forGinkgo
  21. Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial.
    Ihl R; Bachinskaya N; Korczyn AD; Vakhapova V; Tribanek M; Hoerr R; Napryeyenko O; GOTADAY Study Group · International journal of geriatric psychiatry · 2013
    Randomized trial410 participantsCognitive Support forGinkgo
  22. Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2012
    Randomized trial216 participantsMental Focus forGinkgo
  23. Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R · Pharmacopsychiatry · 1996
    Randomized trial216 participantsMental Focus forGinkgo
  24. Ginkgo biloba extract improved cognitive and neurological functions of acute ischaemic stroke: a randomised controlled trial.
    Li S; Zhang X; Fang Q; Zhou J; Zhang M; Wang H; Chen Y; Xu B; Wu Y; Qian L; Xu Y · Stroke and vascular neurology · 2021
    Randomized trial348 participantsMental Focus forGinkgo
  25. Ginkgo biloba in the Aging Process: A Narrative Review.
    Barbalho SM; Direito R; Laurindo LF; Marton LT; Guiguer EL; Goulart RA; Tofano RJ; Carvalho ACA; Flato UAP; Capelluppi Tofano VA; Detregiachi CRP; Bueno PCS; Girio RSJ; Araújo AC · Antioxidants (Basel, Switzerland) · 2024
    Narrative review14 studies pooledMental Focus forGinkgo
  26. [Ginkgo biloba extract EGb 761 in the treatment of dementia: evidence of efficacy and tolerability].
    Kasper S; Schubert H · Fortschritte der Neurologie-Psychiatrie · 2009
    Meta-analysis10 studies pooledProductivity Boost forGinkgo
  27. Limited cognitive benefits in Stage +2 postmenopausal women after 6 weeks of treatment with Ginkgo biloba.
    Elsabagh S; Hartley DE; File SE · Journal of psychopharmacology (Oxford, England) · 2005
    Randomized trial87 participantsProductivity Boost forGinkgo
  28. Efficacy and safety of Ginkgo biloba extract EGb 761 in mild cognitive impairment with neuropsychiatric symptoms: a randomized, placebo-controlled, double-blind, multi-center trial.
    Gavrilova SI; Preuss UW; Wong JW; Hoerr R; Kaschel R; Bachinskaya N; GIMCIPlus Study Group · International journal of geriatric psychiatry · 2015
    Randomized trial160 participantsProductivity Boost forGinkgo
  29. Modulation of cognitive performance following single doses of 120 mg Ginkgo biloba extract administered to healthy young volunteers.
    Kennedy DO; Jackson PA; Haskell CF; Scholey AB · Human psychopharmacology · 2008
    Randomized trial78 participantsProductivity Boost forGinkgo
  30. Effect of Ginkgo biloba extracts in the prevention of posterior capsule opacification after cataract surgery: A randomized clinical trial.
    Amiri AA; Jafari R; Amiri AA; Rad HA; Daneshvar F; Charati JY; Amiri AA · Oman journal of ophthalmology · 2025
    Randomized trial144 participantsVision Support forGinkgo
  31. Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma.
    Quaranta L; Bettelli S; Uva MG; Semeraro F; Turano R; Gandolfo E · Ophthalmology · 2003
    Randomized trial27 participantsVision Support forGinkgo
  32. Short-term effects of Ginkgo biloba extract on peripapillary retinal blood flow in normal tension glaucoma.
    Park JW; Kwon HJ; Chung WS; Kim CY; Seong GJ · Korean journal of ophthalmology : KJO · 2012
    Randomized trial30 participantsVision Support forGinkgo
  33. [The course of color vision in early diabetic retinopathy treated with Ginkgo biloba extract. A preliminary double-blind versus placebo study].
    Lanthony P; Cosson JP · Journal francais d'ophtalmologie · 1989
    Randomized trial29 participantsVision Support forGinkgo